title: Influence of mannan and glucan on complement activation and C3 binding by Candida albicans.
abstract: The complement system is important for host resistance to hematogenously disseminated candidiasis. However, modulation of complement activation by cell wall components of Candida albicans has not been characterized. Although intact yeast display mannan on the surface, glucan, typically located in the interior, becomes exposed during C. albicans infection. We show here the distinct effects of mannan and glucan on complement activation and opsonophagocytosis. Previous studies showed that intact cells are resistant to initiation of complement activation through the alternative pathway, and antimannan antibody reverses this resistance via an Fc-independent mechanism. The present study shows that this mannan-dependent resistance can be overcome by periodate-borohydride conversion of mannose polysaccharides to polyalcohols; cells treated with periodate-borohydride initiate the alternative pathway without the need for antibody. These observations identify an inhibitory role for intact mannan in complement activation. Next, removal of the surface-displayed mannan by acid treatment of periodate-borohydride cells exposes glucan. Glucan-displaying cells or purified beta-glucan initiate the alternative pathway when incubated with the purified proteins of the alternative pathway alone, suggesting that C. albicans glucan is a natural activator of the alternative pathway. Finally, ingestion of mannan-displaying cells by human neutrophils requires anti-mannan antibody, whereas ingestion of glucan-displaying cells requires complement. These results demonstrate a contrasting requirement of natural antibody and complement for opsonophagocytosis of C. albicans cells displaying mannan or glucan. Thus, differential surface expression of mannan and glucan may influence recognition of C. albicans by the complement system.
authors.affiliation: Department of Biological Sciences, California State University-Long Beach, Long Beach, CA 90840, USA.
authors.forename: Gayle M
authors.initials: GM
authors.lastname: Boxx
authors.forename: Thomas R
authors.initials: TR
authors.lastname: Kozel
authors.forename: Casey T
authors.initials: CT
authors.lastname: Nishiya
authors.forename: Mason X
authors.initials: MX
authors.lastname: Zhang
mesh_terms: D002176:Candida albicans / Q000276:immunology*; D003167:Complement Activation / Q000187:drug effects*; D003176:Complement C3 / Q000378:metabolism*; D003170:Complement Pathway, Alternative / Q000187:drug effects; D005936:Glucans / Q000494:pharmacology*; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology*; D008351:Mannans / Q000494:pharmacology*; D009504:Neutrophils / Q000276:immunology; D009895:Opsonin Proteins / Q000378:metabolism; D010587:Phagocytosis / Q000187:drug effects; D011485:Protein Binding
chemical_list: C038245:C3 protein, human; D003176:Complement C3; D005936:Glucans; D007155:Immunologic Factors; D008351:Mannans; D009895:Opsonin Proteins